Dr Reddys Laboratories (RDY) Raw Materials (2009 - 2017)
Dr Reddys Laboratories (RDY) posted Raw Materials of $103.9 million for Q4 2017, down 2.44% on a QoQ basis from $106.5 million in Q3 2017.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Raw Materials (2009 - 2017) Analysis & Trends
Dr Reddys Laboratories has reported Raw Materials for 3 years, with the latest figure at $103.9 million in Q4 2017.
- On a quarterly basis, Raw Materials changed N/A year-over-year to $103.9 million in Q4 2017; TTM through Dec 2017 was $103.9 million, a N/A change from a year earlier, with the FY2017 full-year figure at $107.8 million, changed N/A from the prior year.
- Raw Materials was $103.9 million for Q4 2017 at Dr Reddys Laboratories, down from $106.5 million in the prior quarter.
- The five-year high for Raw Materials was $122.0 million in Q4 2014, with the low at $99.3 million in Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 103.90 Mn |
| Sep 30, 2017 | 106.50 Mn |
| Jun 30, 2017 | 108.45 Mn |
| Mar 31, 2017 | 107.92 Mn |
| Dec 31, 2014 | 122.04 Mn |
| Jun 30, 2014 | 111.35 Mn |
| Mar 31, 2014 | 99.29 Mn |
| Jun 30, 2009 | 82.39 Mn |
| Mar 31, 2009 | 70.94 Mn |